Uncertainty And Questions Surrounds Bladder-Pain Drug Elmiron

Many questions are surrounding the anti bladder pain drug Elmiron, and also a few facts do not add up

Friday, March 19, 2021 - The first question that is being asked is why Johnson & Johnson has enjoyed a monopoly on selling Elmiron (pentosan polysulfate sodium or PPS) for almost three decades. The drug was approved by the US Food and Drug Administration in 1996. Why has no competition entered the market? Another anomaly surrounding Elmiron is a study that claims that the drug is no more effective in treating interstitial cystitis (IC) bladder pain than a placebo. Johnson & Johnson tells patients who take the drug that it takes six to twelve months for the drug to build up in the blood before pain relief can be expected, but is the pain relief all in the patient's head? PelvicSanity.com writes, "Though many urologists prescribe Elmiron(R) to patients and ask them to wait 6-12 months to see if it works, there are many other treatment options that are recommended by the American Urological Association. At best, Elmiron(R) has been shown to benefit only 1 out of 3 patients; at worse, it is no more effective than a placebo and causes significant side effects." Another questionable item about Elmiron is that once a patient starts taking Elmiron, they can never stop, or else the pain will return. Elmiron is not a medicine but only a bandaid. Elmiron does not improve the condition, it only treats the pain, and as I mentioned above, even that is questionable. Elmiron Eye lawsuits are handled by top national attorneys with vast experience and a winning track record litigating against big pharmaceutical companies.

Of all of the reasons to think that the mild side effect claims of Johnson & Johnson subsidiary Janssen Pharmaceutical should not be believed are the women that have come forward and filed lawsuits that allege taking Elmiron to cause them to experience profound eyesight damage. Women taking Elmiron have developed maculopathy and macular degeneration that is permanent and irreversible. People with this condition have trouble seeing in less than optimal lighting conditions like reading or driving at night. Not only that, studies have demonstrated that the longer the time that one has taken Elmiron, the greater the vision loss. Even if a person stops taking Elmiron, the vision damage will not reverse itself and may even continue to progress. AboutLawsuits.com has published a piece about an Elmiron Study conducted by researchers from the University of Kentucky and published in "Current Opinion in Ophthalmology," that claims that upwards of 20% of the millions of women that have taken Elmiron over the years will experience eyesight damage to one degree or another.

Perhaps the most questionable and even sinister aspect of the anti bladder pain drug Elmiron is the potential misdiagnosis of its night blindness side effects. For decades, senior citizens have been diagnosed with a condition called "age-related" macular degeneration, blaming the eyesight damage on a person's advancing age. If you have been misdiagnosed with age-related macular degeneration and have taken anti-bladder pain drug Elmiron, you should speak with an Elmiron Blindness attorney to see if you qualify to file a claim in court.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.